Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 2

Status

Completed 17Terminated 7Active not recruiting 7Recruiting 6Unknown 4Withdrawn 3No longer available 1

Sponsor Class

OTHER 6INDUSTRY 4NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Tumor-Agnostic 2Other solid neoplasm 1Dermatologic 1CNS 1Breast 1

Conditions

Vascular Malformations 1Solid Tumor 1Skin Diseases, Vascular 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Lymphatic Abnormalities 1Lymphangioma, Cystic 1Lymphangioma 1Breast Neoplasms 1Arteriovenous Malformations 1

Interventions

Specimen Handling 336Magnetic Resonance Spectroscopy 333Radiotherapy 315Cyclophosphamide 295pembrolizumab 282Cisplatin 266Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 206Bevacizumab 187Gemcitabine 177venetoclax 172Radiosurgery 169Capecitabine 165Oxaliplatin 163fludarabine 160Nivolumab 156Paclitaxel 155Standard of Care 137Surveys and Questionnaires 131Surgical Procedures, Operative 130Dexamethasone 127Fluorouracil 125Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104atezolizumab 101Azacitidine 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × OTHER × Alpelisib × Clear all
NCT05983159 2026-05-05

TARGET-VM

Murdoch Childrens Research Institute

Phase 2 Recruiting
50 enrolled

Arteriovenous Malformations, Lymphangioma, Skin Diseases, Vascular, Lymphangioma, Cystic, Lymphatic Abnormalities, Vascular Malformations

NCT06545682 2026-04-16

Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)

M.D. Anderson Cancer Center

Phase 1 Recruiting
50 enrolled
BreastDermatologic

Breast Neoplasms, Melanoma

NCT05933395 2026-01-20

GERTRUDE

Dartmouth-Hitchcock Medical Center

Phase 2 Recruiting
135 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT06739395 2024-12-18

Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion

Tianjin Medical University Second Hospital

Phase 2 Recruiting
300 enrolled
Other solid neoplasm

Solid Tumor

NCT03631953 2024-08-06

ALTREM

Assistance Publique Hopitaux De Marseille

Phase 1 Recruiting
25 enrolled
CNS

Meningioma

NCT02925234 2024-01-24

DRUP

The Netherlands Cancer Institute

Phase 2 Recruiting
1,550 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡